Sign inJoin waitlistJoin the waitlist

Meghen Browning

Pediatrics / Pediatric Hematology-Oncology

Credentials: · ·

History

Hematology and Medical Oncology
1998–2001
Internal Medicine
1995–1998
Univ of Wisconsin Sch of Med and Public Health
1991–1995

Research

Rapamycin enriches for CD4(+) CD25(+) CD27(+) Foxp3(+) regulatory T cells in ex vivo-expanded CD25-enriched products from healthy donors and patients with multiple sclerosis
Cytotherapy · 2007 · 38 citations
Expanding the phenotype of multifocal lymphangioendotheliomatosis with thrombocytopenia
Case report · Pediatric Blood & Cancer · 2009 · 23 citations
The T cell activation marker CD150 can be used to identify alloantigen-activated CD4(+)25+ regulatory T cells
Cellular Immunology · 2004 · First of 7 authors · Corresponding · 15 citations

Annette Segura
2 papers
Johnny Hong
2 papers
JK
Joohyun Kim
2 papers · 2 as a fellow
Michael Zimmerman
2 papers
Nghia Vo
2 papers
Paula North
2 papers
Stacee Lerret
2 papers
Aaron Weiss
1 paper
Amanda Brandow
1 paper
Amanda Scheurmann
1 paper · 1 as a resident
Amy Wagner
1 paper
AF
Andrew Foy
1 paper

Clinical trials

A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
Site PI · Recruiting · Phase 2
Eli Lilly and Company
2020–2027